An Examination of the Effect of Registration Errors on FDG-PET Evaluation of Chemotherapy Response in Sarcoma

被引:0
|
作者
Wolsztynski, E. [1 ]
O'Sullivan, F. [1 ]
Roy, S. [1 ]
O'Sullivan, J. [1 ]
Eary, J. F. [2 ]
机构
[1] Univ Coll Cork, Sch Math Sci, Dept Stat, Western Gateway Bldg,Coll Rd, Cork, Ireland
[2] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
Statistical quantitators that summarise standardized uptake value (SUV) distributions are widely used measures of metabolic activity in the analysis of static Positron Emission Tomography (PET) data. Amongst them, SUV mean and total lesion glycolysis (TLG) have been shown to yield a strong prognostic value for many diseases, which contributed to the rapid expansion of PET-based assessment of diagnosis, prognosis and treatment monitoring methodologies. Such measures, however, remain utilized in a point-wise fashion, that is, without a complementary assessment of their accuracy. Without such information, it is not clear that the assessment would be reliable. This raises important questions in particular for prognosis and therapeutic assessment. We consider here a statistical method that was recently proposed for the monitoring of neoadjuvant chemotherapy for sarcoma. This approach consists in pairing pre- and post-therapy scans in order to quantify the response to therapy, in terms of change in mean tracer uptake, along with an associated estimated accuracy. Pairing the uptake information requires co-registering the two sets of images, which most likely introduces a mis-registration error in the analytic framework. We propose to examine the effect of this mis-registration in a quantified analysis where we formulate the problem as a comparison with a classical (unpaired) therapeutic assessment. We demonstrate that mis-registration should not prevent paired-based methodologies. In particular, the derived measure of assessment accuracy remains more powerful even for large typical mis-registration scales. The viability of this method and its effect on prognostic utility are further considered via multivariate Cox survival analyses on a clinical dataset of 50 sarcoma studies with extensive follow-up information. Encouraging results suggest this approach could generalize to the analysis of other diseases and imaging modalities.
引用
收藏
页码:2876 / 2880
页数:5
相关论文
共 50 条
  • [41] Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma
    Bailly, Clement
    Leforestier, Rodolphe
    Campion, Loic
    Thebaud, Estelle
    Moreau, Anne
    Kraeber-Bodere, Francoise
    Carlier, Thomas
    Bodet-Milin, Caroline
    PLOS ONE, 2017, 12 (08):
  • [42] Necrosis evaluation at staging FDG-PET in Osteosarcoma and Ewing sarcoma: SUV prognostic value
    Di Dato, R.
    Allocca, M.
    Martini, A.
    Tamburini, A.
    Olianti, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S343 - S343
  • [43] Utility of bone scintigraphy as an adjunct to FDG-PET in the initial evaluation of Ewing's sarcoma
    DeLonga, David
    Baker, Amanda
    Treves, S. Ted
    Grant, Frederick
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [44] A Novel Approach to the Assessment of Response to Chemotherapy in Sarcoma Imaged with PET-FDG
    Wolsztynski, Eric
    O'Sullivan, Finbarr
    Conrad, Ernest U.
    O'Sullivan, Janet
    Eary, Janet F.
    2010 IEEE NUCLEAR SCIENCE SYMPOSIUM CONFERENCE RECORD (NSS/MIC), 2010, : 2957 - 2962
  • [45] Potential role of [18F]FDG-PET/CT in the evaluation of therapy response after neoadjuvant chemotherapy
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 159 - 159
  • [46] Response evaluation by CT and FDG-PET/CT in malignant pleural mesothelioma
    Schaefer, N. G.
    Veit, P.
    Steinert, H.
    Stahel, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma
    Veit-Haibach, Patrick
    Schaefer, Niklaus G.
    Steinert, Hans C.
    Soyka, Jan D.
    Seifert, Burkhardt
    Stahel, Rolf A.
    LUNG CANCER, 2010, 67 (03) : 311 - 317
  • [48] Response evaluation in malignant pleural mesothelioma (MPM) with FDG-PET/CT
    Dellea, MMS
    Burger, C
    Hany, TF
    Seifert, B
    Jermann, M
    Kung, M
    Stahel, RA
    Steinert, HC
    von Schulthess, GK
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S408 - S408
  • [49] Role of FDG-PET in Yttrium-90 treatment response evaluation
    Seraj, Siavash Mehdizadeh
    Jahangiri, Pegah
    Zadeh, Mahdi Zirakchian
    Al-zaghal, Abdullah
    Werner, Thomas
    Zhuang, Hongming
    Alavi, Abass
    Hunt, Stephen
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [50] A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
    Hildebrandt, Malene Grubbe
    Naghavi-Behzad, Mohammad
    Vogsen, Marianne
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (05) : 520 - 530